Proportions of patients in remission, responders 70 and responders 100 at week 8
| Pooled placebo | 0.5 mg LAQ | 1.0 mg LAQ | 1.5 mg LAQ | 2.0 mg LAQ | |
|---|---|---|---|---|---|
| N | 63 | 29 | 30 | 29 | 29 |
| Clinical remission | |||||
| n (%) | 10 (15.9) | 14 (48.3) | 8 (26.7) | 4 (13.8) | 5 (17.2) |
| 95% CI | (8.9 to 26.8) | (31.4 to 65.6) | (14.2 to 44.4) | (5.5 to 30.6) | (7.6 to 34.5) |
| Response 100 | |||||
| n (%) | 20 (31.7%) | 16 (55.2%) | 12 (40.0%) | 8 (27.6%) | 8 (27.6%) |
| 95% CI | (21.6 to 44.0) | (37.5 to 71.6) | (24.6 to 57.7) | (14.7 to 45.7) | (14.7 to 45.7) |
| Response 70 | |||||
| n (%) | 22 (34.9) | 18 (62.1) | 16 (53.3) | 9 (31.0) | 8 (27.6) |
| 95% CI | (24.3 to 47.2) | (44.0 to 77.3) | (36.1 to 69.8) | (17.3 to 49.2) | (14.7 to 45.7) |